Article
Is lymphocyte adenosine a diagnostic marker of clinical malignant hyperthermia? A pilot study.
Critical care medicine - 1 Mar 2015
Bina Saiid, Capacchione John, Munkhuu Bayarsaikhan, Muldoon Sheila, Bünger Rolf
Abstract excerpt
OBJECTIVE: Malignant hyperthermia is a pharmacogenetic disorder typically triggered by potent inhalation anesthetics and/or the depolarizing muscle relaxant succinylcholine in malignant hyperthermia-susceptible individuals. Since lymphocytes express the same Ca channel mutation found in malignant hyperthermia-susceptible muscle, we investigated agonist-induced adenosine formation in lymphocytes as an index of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
